Loading quotes...
Forecast
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Fresenius SE: €100 investment three years ago would be worth +55.95%
If €100 had been invested in Fresenius SE three years ago, you would now hold 3.563 shares with a value of €155.95, equivalent to a performance of 55.95%. The price rose from €28.07 to €43.78 (as of 06.10.2026). Fresenius SE most recently reached a market capitalization of €24.71 billion. Stock splits and dividends are not included in the calculation. » More on finanzen.net
Fresenius SE investment ten years ago would have resulted in about a 37% loss
Ten years ago the Fresenius SE share traded at €72.77; on 22 September 2026 the price was €45.57. An investment of €1,000 ten years ago would now be worth only about €626.22 (−37.38%), with stock splits and dividends not included in the calculation. Fresenius SE’s market capitalization was most recently around €25.40 billion. » More on finanzen.net
Fresenius SE share: one-year loss of 3.69% on a €1,000 investment
A €1,000 investment in Fresenius SE one year ago (closing price €46.50) would have been worth only €963.12 on 01.09.2026 at a price of €44.79, corresponding to a loss of 3.69%. The most recently reported market value of Fresenius SE is €25.48 billion. The calculation does not take stock splits or dividend payments into account. » More on finanzen.net
Fresenius SE: 10-year investment would mean around 30% loss
An investment of 100 EUR in Fresenius SE ten years ago would, according to calculations, be worth about 70.05 EUR today, a decline of 29.95%. Ten years ago the share closed at 65.45 EUR; the closing price on 25.08.2026 was 45.85 EUR. The market valuation most recently is 25.93 billion euros. The calculation does not take into account stock splits and dividends. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 5.8bn | 5.80% |
| Gross profit | 1.45bn | 11.69% |
| Net profit | 403m | 17.15% |
| EBITDA | 912m | 9.09% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €29.63bn |
Number of shares | 563.24m |
52-week high/low | €53.27 - €35.11 |
Dividend yield | 1.97% |
Dividends TTM | €1.05 |
Beta | 0.77 |
P/E ratio | 18.39 |
PEG ratio | 0.46 |
P/B ratio | 1.44 |
P/S ratio | 1.25 |
Company profile
| Name | Fresenius |
| CEO | Michael Sen |
| Headquarters | Bad Homburg vor der Höhe,
he Germany |
| Website | |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Employees | 178,394 |